Scarica l'app Stockscreener
7.48
3.03%
0.22
Dopo l'orario di chiusura:
7.47
-0.01
-0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.26
Aprire:
$7.43
Volume 24 ore:
1.27M
Relative Volume:
1.07
Capitalizzazione di mercato:
$565.11M
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-3.0531
EPS:
-2.45
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
+2.47%
1M Prestazione:
+7.94%
6M Prestazione:
-8.05%
1 anno Prestazione:
-15.00%
Intervallo 1D:
$7.23
$7.69
Intervallo di 1 settimana:
$6.95
$7.69
Portata 52W:
$4.70
$10.44
Mind Medicine Inc Stock (MNMD) Company Profile
Nome
Mind Medicine Inc
Settore
Industria
Telefono
212-220-6633
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Confronta MNMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
7.48 | 539.45M | 11.40B | -95.73M | -64.37M | -2.45 |
|
ONC
Beone Medicines Ltd Adr
|
245.93 | 25.76B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.43 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.415 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.10 | 6.44B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.81 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Evercore ISI | Outperform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-10-14 | Ripresa | Leerink Partners | Outperform |
| 2024-07-24 | Iniziato | ROTH MKM | Buy |
| 2024-05-29 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-15 | Iniziato | Leerink Partners | Outperform |
| 2023-12-05 | Iniziato | Canaccord Genuity | Buy |
| 2022-12-09 | Ripresa | ROTH Capital | Buy |
| 2022-11-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-26 | Iniziato | Oppenheimer | Outperform |
| 2022-08-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Iniziato | ROTH Capital | Buy |
| 2021-06-28 | Iniziato | Maxim Group | Buy |
Mostra tutto
Mind Medicine Inc Borsa (MNMD) Ultime notizie
Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade - Nasdaq
MindMed Issues Inducement Grants to New Employees - TipRanks
MindMed Appoints Brandi Roberts as CFO to Drive Growth and Commercialization - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treat - GuruFocus
MindMed (MNMD) Poised for Breakthrough in Anxiety Disorder Treatment | MNMD Stock News - GuruFocus
Cantor Fitzgerald maintains Overweight rating on MindMed stock By Investing.com - Investing.com India
MindMed to Participate in June Investor Conferences | MNMD Stock News - GuruFocus
MindMed to Participate in June Investor Conferences - The Globe and Mail
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer - StreetInsider
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD S - GuruFocus
Mind Medicine Names Brandi Roberts CFO - marketscreener.com
Mindmed Strengthens Executive Team With Appointment Of Brandi Roberts As Chief Financial Officer - marketscreener.com
Mind Medicine Appoints New Chief Financial Officer - TipRanks
Mind Medicine (MNMD) Appoints Brandi Roberts as New CFO | MNMD Stock News - GuruFocus
MindMed appoints Brandi L. Roberts as CFO By Investing.com - Investing.com India
MindMed appoints Brandi L. Roberts as CFO - Investing.com Australia
2 ‘Strong Buy’ Psychedelic Stocks To Scoop Up ASAP - Barchart.com
MindMed Appoints Brandi Roberts, CPA, as Chief Financial Officer - citybiz
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer | MNMD Stock News - GuruFocus
(MNMD) Trading Signals - news.stocktradersdaily.com
Analysts Set Expectations for MNMD Q1 Earnings - Defense World
FY2025 EPS Estimates for MNMD Cut by Cantor Fitzgerald - Defense World
Northern Trust Corp Has $4.77 Million Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed at RBC Conference: Progress in Psychedelic Therapies By Investing.com - Investing.com India
MindMed at RBC Conference: Progress in Psychedelic Therapies - Investing.com
Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential - Insider Monkey
MNMD Stock Rises Amid Connecticut's Psilocybin Decriminalization Bill - GuruFocus
Why Mind Medicine Stock Vaulted More Than 8% Higher Today - Yahoo
Mind Medicine (MNMD) Stocks Climb Amid FDA Focus on Psychedelics - GuruFocus
Psychedelic stocks up after FDA chief’s comments (ATAI:NASDAQ) - Seeking Alpha
13 Best Multibagger Stocks to Invest in Now - Insider Monkey
MindMed Announces New Employee Inducement Grants | MNMD Stock News - GuruFocus
MindMed Announces New Employee Inducement Grants - Business Wire
Price T Rowe Associates Inc. MD Acquires 8,361 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Was Jim Cramer Right About Mind Medicine (MNMD) Stock? - Insider Monkey
(MNMD) Technical Data - news.stocktradersdaily.com
Mind Medicine (MindMed) (NASDAQ:MNMD) Upgraded at Cantor Fitzgerald - Defense World
Analysts Offer Predictions for MNMD FY2025 Earnings - Defense World
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Rating of “Buy” by Analysts - Defense World
Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? - MSN
Raymond James Financial Inc. Makes New $111,000 Investment in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
MindMed projects 2026 trial readouts for pivotal MM120 studies in GAD and MDD - MSN
MindMed to Present at the 2025 RBC Capital Markets Global Health - GuruFocus
MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference - The Joplin Globe
Mind Medicine (MindMed)’s (MNMD) “Buy” Rating Reiterated at Chardan Capital - Defense World
MindMed to Host Key Opinion Leader Webinar on Substance Use Diso - GuruFocus
Mind Medicine (MNMD) Rating and Price Target Maintained by Chard - GuruFocus
Psychedelic: Compass, GH Research, MindMed report quarterly earnings - Yahoo Finance
Rising Leaders 2025: Rob Barrow On Leading MindMed’s Psychedelic Renaissance - insights.citeline.com
Mind Medicine Inc (MNMD) Q1 2025 Earnings Call Highlights: Strategic Advances Amidst Financial ... - Yahoo Finance
Mind Medicine Inc Azioni (MNMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):